Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | OCGN | Common Stock | Options Exercise | $11.8K | +42K | +84% | $0.28 | 92K | Aug 11, 2022 | Direct | |
transaction | OCGN | Common Stock | Sale | -$122K | -42K | -45.65% | $2.91* | 50K | Aug 11, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | OCGN | Option (Right to Buy) | Options Exercise | $0 | -42K | -77.78% | $0.00 | 12K | Aug 11, 2022 | Common Stock | 42K | $0.28 | Direct | F2 |
Id | Content |
---|---|
F1 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.89 to $2.94. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
F2 | The options, initially representing a right to purchase 54,000 shares, vest and become exercisable in equal monthly installments over three years commencing on May 5, 2020, subject to continued service with the Company on the applicable vesting dates. |